Combining mobile nursing, teletrials and a dedicated oncology unit, Affinity Clinical Research Services brings clinical research capability directly to patients across Perth and the wider Australian continent. Operating from Doubleview in Western Australia and from a research facility within Hollywood Private Hospital Medical Centre, the organisation serves pharmaceutical sponsors, biotechnology companies and independent investigators seeking a flexible, patient-centred site partner.
Affinity's service model covers the full research lifecycle, from protocol development and site feasibility through participant recruitment, data collection and publication support. The company's direct-to-patient and mobile trial services reduce the burden on participants who would otherwise be unable to access a fixed trial site, extending sponsor reach into regional and rural populations. This approach aligns with ICH-GCP guidelines and is adapted to the specific needs of each patient group and study design.
The dedicated oncology division, Affinity Oncology, was established in 2016 and draws on clinical staff with more than a decade of experience in cancer trials. On-site resources include PET/CT imaging, a compounding pharmacy and a chemotherapy infusion suite, allowing complex oncology studies to run without reliance on third-party facilities. Beyond oncology, Affinity supports studies across a broad range of therapeutic areas and can assist private investigators running sponsor-initiated or investigator-initiated research.
Further information is available at affinityresearch.com.au.